Urinary Retention After Removing Urinary Catheter at 24 Hour Versus 48 Hour in Patients With Vagi… (NCT04954443) | Clinical Trial Compass
CompletedNot Applicable
Urinary Retention After Removing Urinary Catheter at 24 Hour Versus 48 Hour in Patients With Vaginal Surgery
Thailand60 participantsStarted 2021-07-01
Plain-language summary
Comparison incident of urinary retention in patients with vaginal surgery of pelvic organ prolapse, who removed urinary catheter at 24 hours versus 48 hours after surgery
Who can participate
Age range
45 Years – 80 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Woman with pelvic organ prolapse, who undergoing vaginal surgery and agrees to participate in this study
* Able to understand and communicate Thai language
Exclusion Criteria:
* Woman with diabetes mellitus with HbA1C \> 10.9%
* Woman with stroke
* Woman with urinary tract infection before surgery
* Woman with urinary retention before surgery
* Woman, who experienced surgery for urinary incontinence
* Woman, with operative complication including of hemorrhagic shock (Blood pressure \< 90/60 mmHg, Heart rate \> 120 beats per minute, Intra-operative blood loss \> or = 750 ml), urinary tract injury, bowel injury
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Urinary retention
Timeframe: Through study completion, an average of 1 year
Trial details
NCT IDNCT04954443
SponsorDepartment of Medical Services Ministry of Public Health of Thailand